Search research articles
Contact Us
Filters
Showing results (281-290 of 328) with videos related to
Page
of 33
Sort By:
Nature Communications
|
January 2, 2025
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Nature Communications
|
June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J Wright, Izabella Zamora, Milan Parikh, et al.
The Oncologist
|
March 3, 2021
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018
Gabriel E Molina, Leyre Zubiri, Justine V Cohen, et al.
JAMA Oncology
|
April 29, 2016
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
Guo Chen, Jennifer L McQuade, David J Panka, et al.
Nature Communications
|
October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy
Xue Bai, Jiani Hu, Allison Betof Warner, et al.
JAMA Oncology
|
July 17, 2015
Rapid Intraoperative Molecular Characterization of Glioma
Ganesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 328) with videos related to
Sort By:
Page
of 33
Nature Communications
|
January 2, 2025
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih-Bo Huang, Taronish Dubash, et al.
Nature Communications
|
June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J Wright, Izabella Zamora, Milan Parikh, et al.
The Oncologist
|
March 3, 2021
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018
Gabriel E Molina, Leyre Zubiri, Justine V Cohen, et al.
JAMA Oncology
|
April 29, 2016
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial
Guo Chen, Jennifer L McQuade, David J Panka, et al.
Nature Communications
|
October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy
Xue Bai, Jiani Hu, Allison Betof Warner, et al.
JAMA Oncology
|
July 17, 2015
Rapid Intraoperative Molecular Characterization of Glioma
Ganesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Page
of 33